J
Jinda Nano Tech
Jinda Nano Tech is a nano-antibacterial technology developer
About Jinda Nano Tech
Jinda Nano Tech (Xiamen) Co., Ltd. is a high-tech enterprise focused on the research, development, production, and sales of nano-antibacterial materials. The company was founded in 2006 and is situated in the Xiamen High-tech Zone, an initiative backed by the Hong Kong-headquartered Jinda Group. This venture was established in collaboration with prominent Chinese scientific institutions and universities, including Xiamen University, to create a dedicated R&D center for nanotechnology. A significant milestone was achieved in 2012 when the company was recognized as one of the top 500 private technology enterprises in China. In January 2019, Jinda Nano Technology secured a Series B funding round of $29.1 million from investors including Shunwei Capital, C&D, and Blueprint Ventures.
The company's business model revolves around providing advanced material solutions to a wide range of industries. Its client base spans sectors such as textiles, footwear, building materials, healthcare, national defense, environmental protection, and cosmetics. Jinda Nano Tech operates on a B2B model, supplying raw materials and specialized products to manufacturers in over a dozen markets globally, including North America, Europe, and various parts of Asia. Revenue is generated through the direct sale of its extensive product portfolio.
Jinda Nano Tech's core offerings are centered around nano-functional materials, primarily featuring antibacterial properties. The product lineup includes four main categories: antibacterial powders (such as nano silver, gold, and copper), antibacterial masterbatches for plastics and fibers, antibacterial solutions, and functional antibacterial fibers and yarns. These products are engineered to provide stable, long-lasting, and broad-spectrum antibacterial efficacy. For instance, their inorganic antibacterial agents can be integrated into coatings, plastics, and ceramics, while their textile finishing agents are used for medical textiles like hospital sheets and bandages to prevent infection. The company holds over 50 patents for its technologies, including patents for the preparation of nano silver inorganic antibacterial powder and nano silver antibacterial solutions, underscoring its strong R&D capabilities.
Source: Dealroom company dataNews
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Jan 2019 | $29M | $116M | Shunwei Capital | — |
| SERIES AEquity / VC | Jul 2018 | $0 | — | Undisclosed | — |
Growth signals
Latest recorded traffic for Jinda Nano Tech is 510 monthly website visits, up 2% over the last three months. Jinda Nano Tech's team declined 8.3% over the past year.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Jinda Nano Tech in its local ecosystem
The Jinda Nano Tech office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Jinda Nano Tech on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Jinda Nano Tech’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.
